Loading...
Sonnet BioTherapeutics Holdings, Inc.
SONN•NASDAQ
Healthcare
Biotechnology
$2.81
$-0.51(-15.36%)
Sonnet BioTherapeutics Holdings, Inc. (SONN) Financial Performance & Income Statement Overview
Review Sonnet BioTherapeutics Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-87.40%
↓ 87.40%
Operating Income Growth
36.95%
↑ 36.95%
Net Income Growth
60.51%
↑ 60.51%
Operating Cash Flow Growth
59.67%
↑ 59.67%
Operating Margin
-1378.09%
↓ 1378.09%
Gross Margin
-343.40%
↓ 343.40%
Net Profit Margin
-1328.60%
↓ 1328.60%
ROE
-777.96%
↓ 777.96%
ROIC
-2080.88%
↓ 2080.88%
Sonnet BioTherapeutics Holdings, Inc. (SONN) Income Statement & Financial Overview
Review Sonnet BioTherapeutics Holdings, Inc.'s (SONN) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.00M | $104392.00 | $0.00 | $0.00 |
| Cost of Revenue | $22193.00 | $4.54M | $21039.00 | $20496.00 |
| Gross Profit | $977807.00 | -$4.43M | -$21039.00 | -$20496.00 |
| Gross Profit Ratio | $0.98 | -$42.47 | ||
| R&D Expenses | $1.89M | $1.20M | $1.73M | $2.15M |
| SG&A Expenses | $1.96M | $1.97M | $1.80M | $1.70M |
| Operating Expenses | $3.85M | -$1.36M | $3.53M | $3.85M |
| Total Costs & Expenses | $3.85M | $3.17M | $3.53M | $3.87M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $3210.00 | $21039.00 | $20496.00 |
| EBITDA | -$2.85M | -$3.17M | -$3.51M | -$3.85M |
| EBITDA Ratio | -$2.85 | -$30.37 | ||
| Operating Income | -$2.85M | -$3.17M | -$3.53M | -$3.87M |
| Operating Income Ratio | -$2.85 | -$30.40 | ||
| Other Income/Expenses (Net) | -$152884.00 | $44781.00 | $23110.00 | $4.23M |
| Income Before Tax | -$3.002M | -$3.13M | -$3.51M | $365425.00 |
| Income Before Tax Ratio | -$3.002 | -$29.97 | ||
| Income Tax Expense | $158400.00 | $0.00 | $0.00 | $4.00 |
| Net Income | -$3.16M | -$3.13M | -$3.51M | $365425.00 |
| Net Income Ratio | -$3.16 | -$29.97 | ||
| EPS | -$1.56 | -$4.77 | -$0.70 | $0.08 |
| Diluted EPS | -$1.56 | -$4.77 | -$0.70 | $0.08 |
| Weighted Avg Shares Outstanding | $2.02M | $655240.00 | $5.04M | $4.62M |
| Weighted Avg Shares Outstanding (Diluted) | $2.02M | $655240.00 | $5.04M | $4.62M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan